[HTML][HTML] Mushroom-derived bioactive compounds potentially serve as the inhibitors of SARS-CoV-2 main protease: An in silico approach
P Rangsinth, C Sillapachaiyaporn, S Nilkhet… - Journal of traditional and …, 2021 - Elsevier
Abstract Background and aim Coronavirus Disease 2019 (COVID-19) caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has now become the world …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has now become the world …
Mushroom-derived bioactive compounds potentially serve as the inhibitors of SARS-CoV-2 main protease: An in silico approach
P Rangsinth, C Sillapachaiyaporn… - … of traditional and …, 2021 - pubmed.ncbi.nlm.nih.gov
Background and aim Coronavirus Disease 2019 (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has now become the world pandemic …
respiratory syndrome coronavirus 2 (SARS-CoV-2) has now become the world pandemic …
Mushroom-derived bioactive compounds potentially serve as the inhibitors of SARS-CoV-2 main protease: An in silico approach
P Rangsinth, C Sillapachaiyaporn… - Journal of Traditional …, 2021 - opus.lib.uts.edu.au
Background and aim Coronavirus Disease 2019 (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has now become the world pandemic …
respiratory syndrome coronavirus 2 (SARS-CoV-2) has now become the world pandemic …
[HTML][HTML] Mushroom-derived bioactive compounds potentially serve as the inhibitors of SARS-CoV-2 main protease: An in silico approach
P Rangsinth, C Sillapachaiyaporn… - Journal of Traditional …, 2021 - ncbi.nlm.nih.gov
Results Our AutoDock study showed that 25 of 36 candidate compounds have the potential
to inhibit the main viral protease based on their binding affinity against the enzyme's active …
to inhibit the main viral protease based on their binding affinity against the enzyme's active …
Mushroom-derived bioactive compounds potentially serve as the inhibitors of SARS-CoV-2 main protease: An in silico approach.
P Rangsinth, C Sillapachaiyaporn… - Journal of Traditional …, 2021 - europepmc.org
Results Our AutoDock study showed that 25 of 36 candidate compounds have the potential
to inhibit the main viral protease based on their binding affinity against the enzyme's active …
to inhibit the main viral protease based on their binding affinity against the enzyme's active …
Mushroom-derived bioactive compounds potentially serve as the inhibitors of SARS-CoV-2 main protease: An in silico approach
P Rangsinth, C Sillapachaiyaporn… - Journal of Traditional …, 2021 - airitilibrary.com
Background and aim: Coronavirus Disease 2019 (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has now become the world pandemic …
respiratory syndrome coronavirus 2 (SARS-CoV-2) has now become the world pandemic …
Mushroom-derived bioactive compounds potentially serve as the inhibitors of SARS-CoV-2 main protease: an in silico approach.
P Rangsinth, C Sillapachaiyaporn, S Nilkhet… - 2021 - cabidigitallibrary.org
Abstract Background and aim: Coronavirus Disease 2019 (COVID-19) caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has now become the world …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has now become the world …
Mushroom-derived bioactive compounds potentially serve as the inhibitors of SARS-CoV-2 main protease: An in silico approach.
P Rangsinth, C Sillapachaiyaporn… - Journal of Traditional …, 2021 - europepmc.org
Results Our AutoDock study showed that 25 of 36 candidate compounds have the potential
to inhibit the main viral protease based on their binding affinity against the enzyme's active …
to inhibit the main viral protease based on their binding affinity against the enzyme's active …
[PDF][PDF] Mushroom-derived bioactive compounds potentially serve as the inhibitors of SARS-CoV-2 main protease: An in silico approach
P Rangsinth, C Sillapachaiyaporn… - Journal of Traditional …, 2021 - opus.lib.uts.edu.au
abstract Background and aim: Coronavirus Disease 2019 (COVID-19) caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has now become the world …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has now become the world …